{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:45:50Z","timestamp":1770137150274,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.amjcard.2017.05.027","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T20:16:50Z","timestamp":1496348210000},"page":"582-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation"],"prefix":"10.1016","volume":"120","author":[{"given":"Alexandra","family":"Silberberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Angaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean C.","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Skanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Demchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Brent","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafna L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Talajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Heilbron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Berall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.05.027_bib1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cjca.2016.07.591","article-title":"2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/STROKEAHA.108.516344","article-title":"Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated","volume":"40","author":"Gladstone","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2017.05.027_bib3","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","article-title":"Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study","volume":"115","author":"Jahangir","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.05.027_bib4","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.2011.659","article-title":"Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation","volume":"305","author":"Conen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2017.05.027_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.05.027_bib6","doi-asserted-by":"crossref","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2017.05.027_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.amjmed.2016.02.028","article-title":"Mortality in patients with atrial fibrillation randomized to edoxaban or warfarin: insights from the ENGAGE AF-TIMI 48 trial","volume":"129","author":"Giugliano","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2017.05.027_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjmed.2013.01.037","article-title":"Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation","volume":"126","author":"Hess","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2017.05.027_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cjca.2015.07.012","article-title":"The risk stratification and stroke prevention therapy care gap in Canadian atrial fibrillation patients","volume":"32","author":"Angaran","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjcard.2014.12.022","article-title":"Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the co-ordinated national network to engage physicians in the care and treatment of patients with atrial fibrillation chart audit)","volume":"115","author":"Patel","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib11","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. A guideline from the American Heart Association and American College of Cardiology Foundation","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib12","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jcjd.2013.01.030","article-title":"Vascular protection in people with diabetes","volume":"37","author":"Stone","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.amjcard.2017.05.027_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cjca.2012.10.007","article-title":"The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure","volume":"29","author":"McKelvie","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cjca.2011.03.004","article-title":"Canadian hypertension education program: the science supporting new 2011 CHEP recommendations with an wmphasis on health advocacy and knowledge translation","volume":"27","author":"Campbell","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib15","first-page":"997","article-title":"Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary","volume":"21","author":"Abramson","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0828-282X(07)70882-6","article-title":"Missed opportunities for the secondary prevention of cardiovascular disease in Canada","volume":"23","author":"Hackam","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2008.06.037","article-title":"Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy","volume":"102","author":"Tsang","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0828-282X(10)70393-7","article-title":"Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada","volume":"26","author":"Braga","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cjca.2012.12.001","article-title":"Identification and management of patients at elevated cardiometabolic risk in Canadian primary care: how well are we doing?","volume":"29","author":"Teoh","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cjca.2013.06.013","article-title":"Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study","volume":"29","author":"Elbarasi","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cjca.2013.07.680","article-title":"Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the World: Insights from the CLARIFY Registry","volume":"30","author":"Gandhi","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2017.05.027_bib22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.cjca.2015.04.007","article-title":"Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian Global Registry of acute coronary events","volume":"31","author":"Wang","year":"2015","journal-title":"Can J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917308639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917308639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:56:47Z","timestamp":1659059807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917308639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0002914917308639"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.05.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}